Evan Feinberg Founder and CEO of Genesis Therapeutics, building and deploying deep learning and foundation-model methods for drug discovery. Previously developed machine-learning methods for molecular property prediction in Vijay Pande’s lab at Stanford and worked as a deep learning consultant at Merck.
Evan Feinberg Founder and CEO of Genesis Therapeutics, building and deploying deep learning and foundation-model methods for drug discovery. Previously developed machine-learning methods for molecular property prediction in Vijay Pande’s lab at Stanford and worked as a deep learning consultant at Merck.